Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosisMichael P. Pender, Rajiv Khanna, Pauline Crooks et al.|JCI Insight|2018Cited by 160
MRI-derived g-ratio and lesion severity in newly diagnosed multiple sclerosisElizabeth N. York, Dawn Lyle, Sarah‐Jane Martin et al.|Brain Communications|2021Cited by 20
Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosisMichael P. Pender, Rajiv Khanna, Peter A. Csurhes et al.|JCI Insight|2020Cited by 20
Symptomatic and objective clinical improvement in progressive multiple sclerosis patients treated with autologous Epstein-Barr virus-specific T cell therapy: interim results of a phase I trialMichael P. Pender, Rajiv Khanna, Peter A. Csurhes et al.|Queensland's institutional digital repository (The University of Queensland)|2017Cited by 0